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INTRODUCTION
The growth hormone (GH)/insulin-like growth factor (IGF1) axis is responsible 
for somatic development, while pituitary GH synthesis and secretion represent the 
integrated processes, controlled by hypothalamic, intrapituitary and peripheral signals, 
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Research article
Somatopause, the complex aspect of  andropause, is recognizable by reduced growth 
hormone - GH/insulin-like growth factor 1 axis function in the ageing male. Soy 
isofl avones (usually genistein and daidzein), which are known for their benefi cial effects 
in the treatment of  ageing symptoms, are active in the pituitary, as well. The immuno-
histomorphometric and –fl uorescent characteristics of  pituitary growth hormone 
secreting cells, in an animal model of  andropause, were examined after a treatment 
with genistein or daidzein. Andropausal Wistar rats were divided into sham operated, 
orchidectomized and genistein or daidzein treated orchidectomized groups. Genistein 
or daidzein (30 mg/kg/day) were administered subcutaneously for three weeks, while 
sham operated and orchidectomized groups received the vehicle alone. Growth hormone 
secreting cells were identifi ed by the peroxidase-antiperoxidase immuno-histochemical, 
and immuno-fl uorescent procedure. The main characteristic of  growth hormone secreting 
cells in soy isofl avones treated groups is a weaker immuno-histochemical staining and 
immuno–fl uorescent signal compared to sham operated and orchidectomized groups. 
The growth hormone secreting cell volume in orchidectomized +genistein or +daidzein 
groups is by 13.8% and 11.9% (p<0.05) smaller respectively, in comparison with the 
orchidectomized group. In orchidectomized +genistein or +daidzein groups, the growth 
hormone secreting cells relative volume density is by 62.5% and 61.0% lower (p<0.05) 
respectively than for the sham operated group, and decreased by 65.4% and 64.0% (p<0.05) 
respectively, compared to the orchidectomized group. It can be concluded that chronic 
genistein or daidzein treatment, in an animal model of  andropause, attenuates immuno-
histomorphometric and –fl uorescent characteristics of  growth hormone secreting cells.
Key words: andropause, GH cells, immuno-fl uorescence, immuno-histochemistry, 
soy isofl avones
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all of  which converge on the GH cells [1] as the specifi c GH/IGF1 axis operative 
component. Andropause represents the culminating phase of  ageing in males [2], i.e. 
the specifi c multi-symptomatic syndrome that is inter alia characterized by reduced 
GH/IGF1 axis function [3], which opens a specifi c thematic subfi eld – somatopause 
within the andropause. An age-related imbalance between the hypothalamic release 
of  somatostatin and the growth hormone releasing-hormone (GHRH) causes a 
morphofunctional weakening of  GH cells [4, 5] with a signifi cant decrease in GH cells 
size and GH content per cell, as well as the GH pulse amplitude decline [6-8]. These 
changes appear to be followed by some adverse somatic consequences [9]. 
During the past several decades, soy isofl avones (usually genistein and daidzein), the 
compounds structurally and functionally similar to 17β-estradiol, have gained signifi cant 
attention from the scientifi c community, primarily owing to their benefi cial effects in 
the treatment of  various ageing symptoms. On the other hand, data illustrating the 
effects of  genistein or daidzein on the GH/IGF1 axis at different ages, and especially 
their effect on the pituitary GH cells histological characteristics, are limited. It was 
observed that genistein effi ciently stimulates GH secretion in adult ewes, which is 
refl ected in reduced GH deposition in the GH cells and elevated plasma GH levels 
[10]. Considering the negligible amount of  estrogen receptors (ER) in GH cells [11], 
the authors proposed an indirect mechanism of  genistein activity, via growth hormone-
releasing hormone (GHRH) [10]. The elaborated GH secretion promoting effect of  
genistein may encourage its potential therapeutic use in somatopause, while daidzein, 
inactive in the GHRH potentiation [12], still has a debatable potential role in this 
complex age-related condition.
Keeping in mind the silencing of  the GH/IGF1 axis with ageing, the following 
negative morphofunctional transformation of  GH cells (as the specifi c axis operative 
component), as well as a promising role of  soy isofl avones in GH cells stimulation, the 
aim of  this study was to investigate the effects of  chronic subcutaneous treatment with 
genistein or daidzein on immuno-histomorphometric and fl uorescent characteristics 
of  GH cells in an animal model of  andropause. Our ambition was to supplement the 
data ‘pool’ in the neglected aspect of  GH cells histological characteristics, after the 
soy isofl avones application in advanced age. Orchidectomy was performed to eliminate 
testicular sex steroids from the hormonal millieu and their potential effects on the GH 
cells.
MATERIALS AND METHODS
Animals and diets
The experiments involved 16-month-old (andropausal) male Wistar rats. They were bred 
at the Institute for Biological Research “Siniša Stanković”, Belgrade, Serbia, housed one 
per cage, exposed to a 12-12 h light-dark cycle and kept at 22±2ºC. Two weeks before 
the experiment, the rats were given a soy-free diet, prepared in cooperation with the 
Department of  Animal Nutrition and Botany, Faculty of  Veterinary Medicine, Belgrade, 
Serbia, and INSHRA PKB, Belgrade, Serbia, according to Picherit et al., (2000) [13] and 
our previous studies [14-16], with corn oil as the fat source. 
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The diet contained per 100 g: 20.3 g casein; 65 g carbohydrate (45 g cornstarch + 20 
g sucrose); 5.2 g corn oil; 3.7 g fi ber (crystalline cellulose); 1.5 g vitamin/mineral mix 
(Ca-phosphate defi cient); 1.8 g calcium-phosphate dibasic; 1g calcium carbonate; 1.5 g 
DL-methionine. Casein and crystalline cellulose originated from Alfa Aesar, Johnson 
Matthey Gmbh & Co. KG, Karlsruhe, Germany; carbohydrate, oil, vitamin/mineral 
mix, calcium carbonate and calcium phosphate from INSHRA PKB, Belgrade, Serbia; 
and DL-methionine from Sigma Chemical Company, St. Louis, MO, USA. Food and 
water were available ad libitum.
Animal treatments
At the age of  15 months experimental animals were bilaterally orchidectomized (Orx; 
n=24 animals) or sham-operated (SO; n=8 animals) under Ketamine anesthesia (15mg/
kg b.w.; Richter Pharma, Wels, Austria). The recovery period lasted two weeks. The 
orchidectomized rats were then divided into three groups of  eight animals (n=8) each. 
The fi rst group was subcutaneously treated with genistein (Nutraceutica, Monterenzio, 
Bologna, Italy; Orx+G), in a dose of  30 mg/kg b.w., every day except on Sundays, 
for 3 weeks. The second orchidectomized group received daidzein (Nutraceutica, 
Monterenzio, Bologna, Italy; Orx+D) at 30 mg/kg b.w., following the same regime. 
Genistein and daidzein were predissolved in a minimal volume of  absolute ethanol 
(0.17 ml) and mixed with sterile olive oil (0.33 ml). The fi nal volume injected was 0.5 
ml per animal. The third orchidectomized group (Orx) and the SO group were given 
the same volume (0.5 ml) of  vehicle alone. Body mass in all groups was weighted 
before the surgery, before the treatment and after the treatment. All the animals (n=32) 
were sacrifi ced by decapitation under ether anesthesia (ether ad narcosis Ph. Iug. III., 
Lek, Ljubljana, Slovenia) 24 h after the last injection. All experimental procedures were 
in compliance with the EEC Directive (86/609/EEC) on the protection of  animals 
used for experimental and other scientifi c purposes, and were approved by the Ethical 
Committee for the Use of  Laboratory Animals of  the Institute for Biological Research 
“Siniša Stanković”, University of  Belgrade.
Light microscopy and immuno-histochemistry
The pituitary glands were excised, fi xed in Bouins’ solution for 48 h and embedded in 
paraplast. Serial 5 m thick tissue sections were deparafi nised in xylol and rehydrated 
in a series of  decreasing concentrations of  ethanol. For light microscopy analysis, GH 
cells were immunolabelled using the peroxidase-antiperoxidase complex (PAP) method 
of  Sternberger et al. (1970) [17]. The endogenous peroxidase activity was blocked by 
incubation in 9 mmol (0.3%) hydrogen peroxide solution in methanol, for 15 min at 
24°C. Before the application of  the specifi c primary antisera, nonspecifi c background 
staining was prevented by incubation of  the sections with nonimmune, i.e. normal 
porcine serum, diluted (1:10) with phosphate buffered saline (PBS) pH 7.4, for 60 min at 
24°C. Sections were then overlaid with the appropriate dilutions of  the specifi c primary 
antibodies (hGHantisera, Dako A/S, Glostrup, Denmark; diluted 1:200 in PBS) for 24 h 
at 24°C. This antibody strongly cross-reacts with rat GH [18]. After washing in PBS for 
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5 min, sections were incubated for 60 min at 24°C with a secondary antibody, swine anti-
rabbit IgG (DAKO, Glostrup, Denmark; diluted 1:100 in PBS), rinsed again in PBS for 
5 min and then incubated with rabbit PAP complex (DAKO A/S, Glostrup, Denmark; 
diluted 1:100 in PBS), for 45 min at 24°C. Binding sites were visualized using 0.05% 
diaminobenzidine (DAB, Serva, Heidelberg, Germany) and 0.03% hydrogen peroxide 
in 0.2 M TRIS-HCl buffer, pH 7.4. The sections were counterstained with hematoxylin 
and mounted in Canada balsam (Molar Chemicals KFT, Budapest, Hungary). For the 
negative control sections, the primary antibody was omitted and replaced by PBS.
Immuno-fl uorescent studies
GH cells were also localized immuno-fl uorescently. In brief, the pituitary sections were 
deparafi nised, rehydrated, washed in PBS and pretreated with blocking normal donkey 
serum (Dako, Glostrup, Denmark), diluted in PBS (1:10). After blocking, sections were 
incubated overnight at 24°C with the specifi c primary antibodies (hGHantisera, Dako 
A/S, Glostrup, Denmark; diluted 1:200 in PBS). After rinsing in PBS, the sections were 
covered, for 2 h at 24°C, with secondary antibody Alexa Fluor 488 donkey anti-rabbit 
IgG (Molecular Probes, Inc., USA; 1:200). Finally, sections were rinsed fi ve times in 
PBS and mounted using Mowiol 4-88 (Sigma-Aldrich, Co., USA). Carl Zeiss AxioVision 
microscope (Zeiss, Germany) was used for the section analysis. The negative controls 
were obtained by replacement of  the primary antibody with a PBS.
Analysis of  fl uorescent images was performed using the Image J 1.47 (public domain 
Java image processing program by National Institutes of  Health (NIH)). The relative 
intensity of  fl uorescence (RIF, %) was measured on 100-150 cells per animal in which 
the nucleus was apparent.
Morphometry 
Morphometrical measurements were performed as described previously [14, 15]. 
Namely, two pituitary sections (5 μm thick) from the superior, three from the middle 
and two from the inferior part (seven horizontal sections, 20 μm apart in total) of  the 
rat pituitary glands were analysed. The point counting method was used at an overall 
magnifi cation of  x1000 [19]. The M42 multipurpose test grid, inserted into the ocular 
of  a Zeiss light microscope (Jena, Germany), was randomly positioned on the pituitary 
section at the beginning of  counting. Counting was carried out on the following 50 test 
fi elds per section. Average values were calculated per pituitary i.e. per animal (7 sections, 
350 test fi elds) and fi ve pituitaries were analyzed per group. Cell volume (Vc, μm3), 
volume of  the nuclei (Vn, μm3) and volume density (percentage of  immunoreactive 
cells in μm3; Vvc, %) were determined for GH-immunoreactive cells. 
The following parameters were counted:
Pn - number of  points hitting on nuclei of  immuno-histochemically labeled cells inside 
the test fi eld
Ptc - number of  points hitting on cytoplasm of  immuno-histochemically labeled cells 
inside the test fi eld
Nn - number of  immuno-histochemically labeled cell nuclei inside the test fi eld. 
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The formula for calculating the nuclei volume was: 
Vn = VVn/ NV 
and that for the cell volume calculation was:
Vc = 1/ NV , where
VVn is – the volume density of  GH cell nuclei and NV - the numerical density of  GH 
cells. Nuclei volume density (VVn) provides information about nuclei attendance in the 
estimated cells and is calculated as follows: 
VVn =ΣPn/ΣPtc
Since rat GH cells are mononuclear, NV corresponds to the number of  cells per cubic 
millimetre, according to the formula: 
NV = (k/β) (NA
3/2 / VVn 
½ )
On the basis of  earlier karyometric studies [20], the shape coeffi cient β for pituitary 
cells was estimated to be 1.32, where k is a factor related to cell distribution according 
to their size (in the case of  GH cells its value is 1) and NA is the number of  cells in the 
plane of  the pituitary tissue section. NA is calculated as follows: 
NA = ΣNn/ΣPtc · a ,
where a represents the rhombic area belonging to every point of  the test system and is 
calculated using the formula: 
a = d2 3 1/2/2 , 
where d is the test line length in the test system employed.
Volume density (VVC) is calculated as the ratio of  the sum of  Pn and Ptc (Pn+Ptc) and 
the total number of  points in the test system. Since the test system with 42 points was 
used and parameters were calculated using 50 test fi elds, the defi nite formula was:
VVC = (Pn+Ptc)/ 50 · 42
Statistical analysis
STATISTICA® version 7.0 (StatSoft, Inc.) was used for the statistical analysis. 
Morphometric and RIF data obtained for the experimental groups were subjected to 
one-way analyses of  variance (ANOVA). Duncan’s multiple range tests were used for 
post hoc comparisons between groups. A confi dence level of  p<0.05 was considered 
statistically signifi cant. The data are presented as means±SD. 
RESULTS
Body mass and pituitary weights
Data for body mass, absolute and relative pituitary weights are summarized in Table 
1. Only in the Orx group the body mass after treatment was signifi cantly (p<0.05) 
decreased (by 9.8%), in comparison with the SO group. Genistein or daidzein treatment, 
after orchidectomy, returned the body mass to the values similar to that of  SO rats. 
Absolute pituitary weight was signifi cantly (p<0.05) increased in Orx+D group by 8.4%, 
compared to the Orx group. The relative pituitary weights were signifi cantly (p<0.05) 
increased in Orx, Orx+G and Orx+D groups by 13.6%, 40.9% and 31.8% respectively, 
in comparison with the SO group. The relative pituitary weight increased by 24.0% 
(p<0.05) for the Orx+G and by 15.0% for the Orx+D, compared to the Orx group. 
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Immuno-histochemical fi ndings
Immunopositive GH cells in SO and Orx rat pituitaries are mainly uniformly distributed, 
bilaterally and rostrocaudally, in the pars distalis, while being completely absent in the 
pituitary pars intermedia. They can be observed as an individual or as a group, especially 
along the sinusoidal capillaries (Fig. 1A, B). SO and Orx rat pituitary GH cells appear 
to be massive, ovoid to pyramidal in shape, with a spherical, centrally located nucleus. 
The immunospecifi c signal, refl ecting the cells’ GH content, is rather dark and widely 
distributed throughout the cytoplasm (Fig. 1A, B). In Orx+G and Orx+D rat pituitaries, 
a small number of  immunopositive GH cells can be observed; they appear as an individual 
or in the form of  small groups, along the sinusoidal capillaries (Fig. 1C, D). The main 
characteristic of  GH cells in soy isofl avones treated groups of  rats is enlightened cytoplasm 
(a weaker intensity of  immunospecifi c staining compared to the control groups), while the 
pituitary capillaries, towards which GH cells gravitate, are dilated (Fig. 1C, D). 
Immuno-fl uorescent fi ndings
Complementary insight into the immuno-fl uorescent appearance of  GH cells confi rmed 
a weaker signal after the soy isofl avone treatments, compared to the control groups (Fig. 
2A-D). Quantifi cation of  the signal revealed that in Orx+G rats RIF is decreased by 41.8% 
and 44.8% (p<0.05) in comparison with the SO and Orx group, respectively (Fig. 2E). 
Daidzein treatment of  orchidectomized andropausal rats (Orx+D) also causes the decrease 
of  RIF for 47.3% and 50.0% (p<0.05) compared to the SO and Orx group, respectively.
Morphometric results
Morphometric analyses showed that GH cells in SO, Orx, Orx+G and Orx+D groups 
of  rats have a mean cell volume (Vc) of  591 μm3, 559 μm3, 482 μm3 and 492 μm3, 
SO Orx Orx+G Orx+D
Body mass before  
surgery (g) 680.0±30.0
Body mass before  
treatment (g) 654.0±8.0 639.0±63.0 639.0±63.0 639.0±63.0
Body mass after  
treatment (g) 650.0±29.0 586.0 ±35.0
a 635.0±57.0b 620.0±46.0b
Absolute pituitary 
weight (mg) 17.0±1.7 16.6±1.4 19.6±1.0
b 18.0±1.4b
Relative pituitary 
weight (mg/%) 2.2±0.1 2.5±0.2
a 3.1±0.2a,b 2.9±0.2a,b
Table 1. Body mass, absolute and relative pituitary weight in sham-operated (SO), 
orchidectomized (Orx), genistein (Orx+G) and daidzein (Orx+D) treated 
orchidectomized andropausal rats.
Means±SD, n=5/group; ap<0.05 vs. sham-operated (SO) rats; bp<0.05 vs. orchidectomized (Orx) rats
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respectively (Fig. 3A). In comparison with SO and Orx groups, the GH cell volume 
in Orx+G group is 18.4% and 13.8% (p<0.05) smaller, respectively (Fig. 3A). The 
mentioned parameter in Orx+D group of  rats is also signifi cantly (p<0.05) decreased 
compared to SO and Orx groups, by 16.8% and 11.9% respectively (Fig. 3A). After 
orchidectomy and orchidectomy followed by soy isofl avones treatment there are no 
signifi cant (p>0.05) changes in the nuclear volumes of  GH cells, in comparison with 
the SO group (Fig. 3B). The GH cells relative volume density data (Vvc; %) in SO, Orx, 
Orx+G and Orx+D groups are shown in Fig. 3C (36.0%, 39.0%, 13.5% and 14.2% 
respectively). Namely, in Orx+G and Orx+D, the relative volume densities are by 
62.5% and 61.0% lower (p<0.05) respectively, than for the SO controls (Fig. 3C). The 
same parameter in Orx+G and Orx+D is signifi cantly (p<0.05) decreased by 65.4% 
and 64.0% respectively, compared to Orx group (Fig. 3C). 
DISCUSSION
Considering the promising data regarding the soy isofl avone effects in ageing, 
somewhat of  their GH/IGF1 axis stimulation, as well as the limited information about 
the GH cells appearance in this context, our intention was to determine the immuno-
histomorphometric and –fl uorescent characteristics of  GH cells in andropausal rats, 
after chronic genistein or daidzein treatment. 
Figure 1. Immunopositive GH cells in pars distalis of  the pituitary gland from: A) sham-operated 
(SO), B) orchidectomized (Orx), C) genistein (Orx+G) and D) daidzein (Orx+D) treated or-
chidectomized andropausal rats (magnifi cation 63x, bar=16 μm)
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In line with our previous fi ndings [14, 15], genistein or daidzein application to 
orchidectomized andropausal rats has some recovering body mass effect, i.e. it brings 
body mass values close to that of  SO rats. We have already demonstrated the pronounced 
daidzein effects on the prevention of  bone loss and calcium excretion in the same 
animal model [21], while Penza et al. [22] observed that nutritional doses of  genistein 
are adipogenic in male mice, all of  which can cause the positive body weight outcome 
in our experiment. It should be mentioned that some studies suggest the absence of  soy 
isofl avones effect on body mass [23], so the cautiousness in concluding is desirable. On 
the other hand, given the age of  animals in our study and their long-ended growth, it is 
quite reasonable to minimize the importance of  some potentional genistein or daidzein 
Figure 2. Immuno-fl uorescent appearance of  GH cells in pars distalis of  the pituitary gland 
from: A) sham-operated (SO), B) orchidectomized (Orx), C) genistein (Orx+G) and D) daidzein 
(Orx+D) treated orchidectomized andropausal rats (bar=20 μm); E) Relative intensity of  fl uo-
rescence (RIF, %) measured in GH cells from SO, Orx, Orx+G and Orx+D groups. All values 
are the means±SD, n=5 animals per group; ap<0.05 vs. SO, bp<0.05 vs. Orx
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effect on the body mass via GH/IGF1 axis. Also, genistein or daidzein treatment 
increases absolute and relative pituitary weight in orchidectomized andropausal rats, 
which is explicable by their presumable estrogenic effect on the pituitary prolactin cells. 
A weaker intensity of  immuno-histochemical staining and immuno–fl uorescent signal 
of  GH cells, followed by their decreased volume and volume density, compared to 
both SO and Orx groups, is observed after genistein or daidzein application in our 
experiment. Genistein, operating as a tyrosine-kinase inhibitor, promotes GHRH-
stimulated cAMP accumulation in GH cells, which potentiates their hormonal content 
secretion [12]. This mechanism may satisfactorily clarify the observed appearance of  the 
cytoplasm of  GH cells after genistein treatment in our study. Furthermore, genistein 
treatment lowered the density of  the immunoreactive material in GH cells of  ewes, 
which indicates decreased hormone storage [10]. Daidzein, although a weak tyrosine-
kinase inhibitor [24], fashions in a similar manner as genistein in orchidectomized 
andropausal rats, which opens the space for some other possible mechanisms of  soy 
isofl avone actions pertinent to GH cells. Literature data indicate the possible alterations 
in somatostatin receptors (SSTRs) expression after genistein application in vitro, as a 
matter of  fact the SSTR1 downregulation, as well as the SSTR2 and SSTR5 upregulation 
[25]. Considering that an alternative SSTR expression in pituitary GH secreting tumors 
causes the insensitivity to somatostatin [26], it seems logical that some soy isofl avone 
modifi ed SSTR expression in GH cells may have a related outcome responsible for 
Figure 3. Cellular (Vc, μm3; A) and nuclear volume (Vn, μm3; B), and 
relative volume density (Vvc, %; C) of  GH cells in: sham-operated (SO), 
orchidectomized (Orx), genistein (Orx+G) and daidzein (Orx+D) treated 
orchidectomized andropausal rats. All values are given as the means±SD, 
n=5 animals per group; ap<0.05 vs. SO, bp<0.05 vs. Orx
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shaping their appearance. 
Based on the above elaborated issues, it can be concluded that chronic genistein 
or daidzein treatment, in an animal model of  andropause, attenuates immuno-
histomorphometric and -fl uorescent characteristics of  GH cells. 
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IMUNO-HISTOMORFOMETRIJSKE I –FLUORESCENTNE 
KARAKTERISTIKE GH ĆELIJA NAKON TRETMANA GENISTEINOM 
ILI DAIDZEINOM U ANIMALNOM MODELU ANDROPAUZE
AJDŽANOVIĆ Vladimir, MEDIGOVIĆ Ivana, ŽIVANOVIĆ Jasmina, ŠOŠIĆ-
JURJEVIĆ Branka, TRIFUNOVIĆ Svetlana, TANIĆ Nasta, MILOŠEVIĆ Verica
Somatopauza, kao kompleksan aspekt andropauze, je prepoznatljiva po sniženom nivou 
funkcije somatotropne - GH ose kod starih mužjaka. Izofl avoni soje (najčešće genistein 
i daidzein), imaju blagotvorne efekte pri tretmanu simptoma starenja, a ispoljavaju 
svoje dejstvo i na nivou hipofi ze. Imuno-histomorfometrijske i – fl uorescentne 
karakteristike hipofi znih somatotropnih ćelija su ispitivane nakon tretmana genisteinom 
ili daidzeinom, u animalnom modelu andropauze. Pacovi Wistar soja u andropauzi su 
podeljeni u nekoliko grupa: prividno operisanu, orhidektomisanu i genisteinom odnosno 
daidzeinom tretiranu orhidektomisanu grupu. Rastvoreni genistein, odnosno daidzein 
(30 mg/kg/dan) su potkožno davani tokom tri nedelje, dok su prividno operisana i 
orhidektomisana grupa dobijale samo rastvarač tokom istog perioda. Somatotropne 
ćelije su identifi kovane peroksidaza-antiperoksidaza imuno-histohemijskom, i imuno-
fl uorescentnom metodom. Osnovna karakteristika somatotropnih ćelija u grupama 
tretiranim izofl avonima soje je slabije imuno-histohemijsko bojenje i slabiji imuno–
fl uorescentni signal u poređenju sa prividno operisanom i orhidektomisanom grupom. 
Volumen somatotropnih ćelija u orhidektomisanoj i genisteinom, odnosno daidzeinom 
tretiranoj grupi je za 13,8%, odnosno 11,9% (p<0,05) smanjen u poređenju sa 
orhidektomisanom grupom. U orhidektomisanoj i genisteinom, odnosno daidzeinom 
tretiranoj grupi volumenska gustina somatotropnih ćelija je za 62,5%, odnosno 61,0% 
niža (p<0,05) nego kod prividno operisane grupe, te za 65,4%, odnosno 64,0% (p<0,05) 
niža u poređenju sa orhidektomisanom grupom. Može se zaključiti da hronični tretman 
genisteinom ili daidzeinom, u animalnom modelu andropauze, ima negativan efekat na 
imuno-histomorfometrijske i – fl uorescentne karakteristike somatotropnih ćelija.
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